Evaluation of pharmacologic treatment of destructive behaviors: Aggregated results from single-case experimental studies

Cathleen C. Piazza, Wayne Fisher, Susan L. Hyman, Jennifer Fleishell, Kai K. Lou, Michael Cataldo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In this investigation, 20 clients with mental retardation and destructive behavior disorders were treated with psychotropic medication based on symptoms associated with a psychiatric disorder. For each patient, single-case design and direct observation procedures were utilized to evaluate outcome. Three clients (15%) showed at least a 50% reduction in destructive behavior; seven (35%) experienced a 50% or greater increase in destructive behavior; 10 (50%) experienced no change in their destructive behavior. The best response was to stimulant medications prescribed on the basis of pervasive hyperactivity and distractibility. The worst response was to lithium prescribed on the basis of manic-like symptoms (e.g., psychomotor agitation) or cyclical behavior disturbance. The low response rate was hypothesized to be a function of the unique underlying brain dysfunction in severely to profoundly retarded individuals with destructive behavior disorders, and the difficulties with applying psychiatric diagnoses in the population. Given the individual variability of response among clients and the prevalence of behavior dysfunction of the population, single-case methodology may have a useful role in the assessment of psychopharmacotherapy with individuals with severe to profound mental retardation and destructive behavior disorders.

Original languageEnglish (US)
Pages (from-to)149-168
Number of pages20
JournalJournal of Developmental and Physical Disabilities
Volume6
Issue number2
DOIs
StatePublished - Jun 1 1994

Fingerprint

Mental Disorders
Lithium
Brain
Intellectual Disability
Therapeutics
Psychomotor Agitation
Population
Psychiatry
Observation

Keywords

  • destructive behaviors
  • mental retardation
  • pharmacologic treatment
  • single-case design

ASJC Scopus subject areas

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Developmental and Educational Psychology

Cite this

Evaluation of pharmacologic treatment of destructive behaviors : Aggregated results from single-case experimental studies. / Piazza, Cathleen C.; Fisher, Wayne; Hyman, Susan L.; Fleishell, Jennifer; Lou, Kai K.; Cataldo, Michael.

In: Journal of Developmental and Physical Disabilities, Vol. 6, No. 2, 01.06.1994, p. 149-168.

Research output: Contribution to journalArticle

@article{ee940a0ed3db4d59811ed2314c8cbeb1,
title = "Evaluation of pharmacologic treatment of destructive behaviors: Aggregated results from single-case experimental studies",
abstract = "In this investigation, 20 clients with mental retardation and destructive behavior disorders were treated with psychotropic medication based on symptoms associated with a psychiatric disorder. For each patient, single-case design and direct observation procedures were utilized to evaluate outcome. Three clients (15{\%}) showed at least a 50{\%} reduction in destructive behavior; seven (35{\%}) experienced a 50{\%} or greater increase in destructive behavior; 10 (50{\%}) experienced no change in their destructive behavior. The best response was to stimulant medications prescribed on the basis of pervasive hyperactivity and distractibility. The worst response was to lithium prescribed on the basis of manic-like symptoms (e.g., psychomotor agitation) or cyclical behavior disturbance. The low response rate was hypothesized to be a function of the unique underlying brain dysfunction in severely to profoundly retarded individuals with destructive behavior disorders, and the difficulties with applying psychiatric diagnoses in the population. Given the individual variability of response among clients and the prevalence of behavior dysfunction of the population, single-case methodology may have a useful role in the assessment of psychopharmacotherapy with individuals with severe to profound mental retardation and destructive behavior disorders.",
keywords = "destructive behaviors, mental retardation, pharmacologic treatment, single-case design",
author = "Piazza, {Cathleen C.} and Wayne Fisher and Hyman, {Susan L.} and Jennifer Fleishell and Lou, {Kai K.} and Michael Cataldo",
year = "1994",
month = "6",
day = "1",
doi = "10.1007/BF02579357",
language = "English (US)",
volume = "6",
pages = "149--168",
journal = "Journal of Developmental and Physical Disabilities",
issn = "1056-263X",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Evaluation of pharmacologic treatment of destructive behaviors

T2 - Aggregated results from single-case experimental studies

AU - Piazza, Cathleen C.

AU - Fisher, Wayne

AU - Hyman, Susan L.

AU - Fleishell, Jennifer

AU - Lou, Kai K.

AU - Cataldo, Michael

PY - 1994/6/1

Y1 - 1994/6/1

N2 - In this investigation, 20 clients with mental retardation and destructive behavior disorders were treated with psychotropic medication based on symptoms associated with a psychiatric disorder. For each patient, single-case design and direct observation procedures were utilized to evaluate outcome. Three clients (15%) showed at least a 50% reduction in destructive behavior; seven (35%) experienced a 50% or greater increase in destructive behavior; 10 (50%) experienced no change in their destructive behavior. The best response was to stimulant medications prescribed on the basis of pervasive hyperactivity and distractibility. The worst response was to lithium prescribed on the basis of manic-like symptoms (e.g., psychomotor agitation) or cyclical behavior disturbance. The low response rate was hypothesized to be a function of the unique underlying brain dysfunction in severely to profoundly retarded individuals with destructive behavior disorders, and the difficulties with applying psychiatric diagnoses in the population. Given the individual variability of response among clients and the prevalence of behavior dysfunction of the population, single-case methodology may have a useful role in the assessment of psychopharmacotherapy with individuals with severe to profound mental retardation and destructive behavior disorders.

AB - In this investigation, 20 clients with mental retardation and destructive behavior disorders were treated with psychotropic medication based on symptoms associated with a psychiatric disorder. For each patient, single-case design and direct observation procedures were utilized to evaluate outcome. Three clients (15%) showed at least a 50% reduction in destructive behavior; seven (35%) experienced a 50% or greater increase in destructive behavior; 10 (50%) experienced no change in their destructive behavior. The best response was to stimulant medications prescribed on the basis of pervasive hyperactivity and distractibility. The worst response was to lithium prescribed on the basis of manic-like symptoms (e.g., psychomotor agitation) or cyclical behavior disturbance. The low response rate was hypothesized to be a function of the unique underlying brain dysfunction in severely to profoundly retarded individuals with destructive behavior disorders, and the difficulties with applying psychiatric diagnoses in the population. Given the individual variability of response among clients and the prevalence of behavior dysfunction of the population, single-case methodology may have a useful role in the assessment of psychopharmacotherapy with individuals with severe to profound mental retardation and destructive behavior disorders.

KW - destructive behaviors

KW - mental retardation

KW - pharmacologic treatment

KW - single-case design

UR - http://www.scopus.com/inward/record.url?scp=51249166914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51249166914&partnerID=8YFLogxK

U2 - 10.1007/BF02579357

DO - 10.1007/BF02579357

M3 - Article

AN - SCOPUS:51249166914

VL - 6

SP - 149

EP - 168

JO - Journal of Developmental and Physical Disabilities

JF - Journal of Developmental and Physical Disabilities

SN - 1056-263X

IS - 2

ER -